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Summary
Background: The epidermal growth factor receptor (EGFR)
and Hippo signaling pathways control cell proliferation and
apoptosis to promote tissue growth during development.
Misregulation of these pathways is implicated in cancer. Our
understanding of the mechanisms that integrate the activity
of these pathways remains fragmentary. This study identifies
bantam microRNA as a common target of these pathways
and suggests a mechanistic link between them.
Results: The EGFR pathway acts through bantam to control
tissue growth. bantam expression is regulated by the
EGFR pathway, acting via repression of the transcriptional
repressor Capicua. Thus EGFR signaling induces bantam
expression by alleviating the effects of a repressor. bantam
in turn acts in a negative feedback loop to limit Capicua
expression.
Conclusions: bantam appears to be a transcriptional target of
both the EGFR and Hippo growth control pathways. Feedback
regulation by bantam on Capicua provides a means to link
signal propagation by the EGFR pathway to activity of the
Hippo pathway and may play an important role in integration
of these two pathways in growth control.
Introduction
Networks of intracellular signal transduction control cell
growth, proliferation, and death to shape tissues and organs
during animal development. Misregulation of these pathways
and the cellular processes they regulate can cause cancer
(reviewed in [1]). Genetic models suggest that tumor formation
depends on inhibition of apoptosis as well as on stimulation of
proliferation [2].
The Hippo/Wts signal transduction pathway plays a key role
in control of normal tissue growth during animal development.
The core of the pathway is a kinase cascade. Hippo, an
MST-family kinase, actswith Salvador to phosphorylateWarts,
anNDR-family kinase, which then actswith its cofactorMats to
phosphorylate the transcription factors Yap/TAZ/Yorkie. Inac-
tivation of the core elements of the pathway has been linked to
tumor formation (reviewed in [3, 4]). This results from increased
activity of members of the Yap/Taz/Yorkie family, which have
been implicated in control of cell proliferation, anchorage-
independent growth, apoptosis, and tumor formation [5–8].
Warts-dependent phosphorylation inactivates Yap and Yorkie
by promoting cytoplasmic retention [8, 9]. Phosphosite muta-
tions that preclude this regulation lead to constitutive YAP/
Yorkie activity and induction of target gene expression [8, 9].*Correspondence: scohen@imcb.a-star.edu.sgIn Drosophila, Yorkie has been shown to control apoptosis
and cell proliferation through targets including the cell-cycle
regulator cyclin E, the inhibitor of apoptosis DIAP1, and
bantammicroRNA (miRNA) [5, 10, 11]. bantam in turn controls
apoptosis by regulation of the proapoptotic gene hid [12].
Similarly, mutations in the epidermal growth factor receptor
(EGFR) and downstream effectors including the PI3K/AKT and
mitogen-activated protein kinase (MAPK) signaling pathways
are prominently featured among the driver mutations in a
variety of human cancers [13–17]. Deregulation of EGFR func-
tion contributes to the growth and survival of cancer cells.
Consequently, antibodies and small molecules that target
EGFR and its downstream effectors have become important
cancer therapeutics [18, 19].
In Drosophila, EGFR signal transduction via the RAS/MAPK
kinase cascade has been implicated in many aspects of
pattern formation as well as in control of tissue growth, cell
proliferation, and apoptosis [20–24]. In Drosophila genetic
models, overexpression of EGFR or expression of the onco-
genic form of activated Ras produces tissue hyperplasia, but
does not lead to overt neoplasia unless additional factors are
activated (reviewed in [25, 26]). The proapoptotic gene hid
is an important target of EGFR pathway in growth control.
EGFR/MAPK signaling via the ETS-family transcription factor
Pointed controls hid transcription, whereas signaling via the
MAPK pathway directly controls Hid activity [27, 28].
The HMG-box protein Capicua has been identified as medi-
ator of EGFR in control of cell proliferation and cell differentia-
tion [29, 30]. Capicua protein levels are thought to be subject to
posttranscriptional regulation by signaling downstream of
the receptor tyrosine kinases, EGFR, and Torso [30, 31]. It
has been suggested that MAPK-mediated phosphorylation
promotes Capicua degradation [32]. Capicua has been shown
to act as a transcriptional repressor through interaction with
the corepressor Groucho [31, 33]. According to this model,
EGFR should act to promote tissue growth by alleviating
Capicua-mediated repression of genes responsible for cell
proliferation and survival. Little is known about EGFR/Capicua
targets in this context. In this report, we present evidence that
bantammiRNA expression is regulated by the EGFR pathway,
acting via Capicua. Thus bantam appears to be a transcrip-
tional target of both the EGFR and Hippo growth control path-
ways. Intriguingly, we also find that bantam acts in a feedback
loop to limit Capicua expression. This provides ameans to link
signal propagation by the EGFR pathway to activity of the
Hippo pathway and may play an important role in integration
of these two pathways in growth control.
Results
Depletion of bantam Produces EGFR-Like Phenotypes
miRNA sponges encoded by UAS-transgenes permit spatially
controlled depletion of miRNAs when expressed under Gal4
control [34]. To facilitate the study of bantam function in the
imaginal discs, we prepared a bantam sponge consisting of
a Discosoma species red fluorescent protein (dsRed) trans-
gene with ten bantam binding sites in its 30UTR. These sites
contain a central bulge to prevent messenger RNA (mRNA)
Figure 1. Depletion of bantam Generates EGFR-Like Phenotypes
(A) Schematic representation of the bantam-sponge. Ten bantam binding sites (depicted as orange blocks) were cloned downstream of dsRed coding
sequence in a pUAST vector. These sites have sequences complementary to bantam miRNA with a central mismatch.Mini-white was used as the genetic
marker for transformation.
(BandC)Confocalmicrographs showing thewingpouch regionof third-instarwing imaginal discs that expressed thebantamsensor transgene (asdescribed
in [12]). The sensor transgene is uniformly expressed, so variation in GFP levels reflects bantam activity, with low GFP indicating higher bantam levels.
(B) apG4 UAS-GFP control. Gal4 and the bantam-sensor are shown separately.
(C) apG4, UAS-dsRED-bantam-sponge. dsRED and the bantam-sensor are shown separately.
(D) Cuticle preparations of adult wings from flies of the indicated genotypes: (top) MS1096-Gal4 UAS-GFP, (middle) MS1096-Gal4 UAS-EGFRRNAi,
and (bottom)MS1096-Gal4 UAS-bantam-sponge.
(E) Histogram plotting wing area. Areas were normalized to the GFP expressing controls. MS1096-Gal4 UAS-EGFRRNAi versus MS1096-Gal4 UAS-GFP
control wings: p = 1.5E-08; MS1096-Gal4 UAS-bantam-sponge versus control wings p = 9E-15). n = 14 wings per genotype. Error bars indicate SD. Adult
female wings were analyzed.
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652cleavage (Figure 1A; [35]). To visualize sponge activity in vivo,
we made use of a GFP sensor transgene with two perfect
bantam target sites in its 30UTR [12]. bantam activity reduces
sensor expression such that high GFP levels reflect low
bantam levels and vice versa. TheUAS-bantam-sponge trans-
gene was expressed in the dorsal compartment of the wing
disc under apterous-Gal4 (apG4) control. Depletion of bantam
with the sponge led to higher GFP sensor levels (Figures 1B
and 1C). The sponge also reduced the size of the dorsal
compartment, consistent with the role of bantam in tissue
growth [12, 36].
Expression of the bantam sponge throughout the wing disc
usingMS1096-Gal4 resulted in small wings (Figure 1D; quanti-
fied in Figure 1E). Reduction of EGFR levels by expression of
a UAS-EGFRRNAi transgene under MS1096-Gal4 control also
reduced wing size (Figures 1D and 1E), consistent with the
role of EGFR/Ras/MAPK signaling in tissue growth and cell
survival [20, 23, 24]. Although EGFR and bantam each act in
part via regulation of the proapoptotic gene hid, removing one
copyof the endogenoushidgenedid not significantlymodulate
the phenoytpes produced by EGFR or bantam depletion.The EGFR Pathway Regulates bantam Expression
In light of the similar effects of reducing EGFR or bantam
activity, we asked whether the EGFR/MAPK pathway regu-
lates bantam expression. To manipulate EGFR pathway
activity, we used apG4 to direct expression of UAS-EGFR
transgene and monitored the effects on bantam using a P
element insertion that reports expression from the bantam
locus (bantam-lacZ; Figure 2A). These experiments were
done in a strain that carriedGal80TS to permit temporal control
of the onset of Gal4 activity by shifting the animals to the
restrictive temperature to inactivate Gal80 [37]. Induction of
EGFR expression for 48 hr led to extensive overgrowth, withthe epithelium thrown into folds because the overgrowing
compartment was constrained by the surrounding tissue (Fig-
ure 2B). EGFR-induced overgrowth was associated with
a robust increase in bantam-lacZ expression (Figure 2B). We
also monitored bantam activity using the bantam sensor (Fig-
ure 2C) and found that sensor levels were reduced (Figure 2D;
for this experiment, larvae were shifted to 29C for 24 hr to
minimize folding of the disc. This facilitated comparison of
sensor levels). Similar results were obtained following expres-
sion of the activated form ofRas to activate theMAPKpathway
downstream of EGFR (RasV12 [38]; see Figure S1 available
online). Thus, elevated EGFR activity increased bantam levels.
Reciprocally, clones of cells mutant for the EGFR null allele,
topF1, or mutant for the RasDC40b null allele showed growth
defects and upregulation of the bantam sensor (Figures 2E
and 2F), indicative of reduced bantam activity. These clones
were smaller than their twins. Taken together, these findings
suggest that EGFR signaling regulates bantam expression.
To ask whether bantam mediates the effects of EGFR
on tissue growth, we compared the effects of expressing the
bantam sponge on the magnitude of overgrowth caused by
expression of EGFR. For this experiment, EGFR overexpres-
sion conditions were chosen to produce massive overgrowth
(29C for 48 hr; Figures 2G and 2H). This overgrowth was
greatly reduced by expression of the UAS-bantam sponge in
place of the UAS-GFP control (Figure 2I). Taken together
with the finding that EGFR signaling regulates bantam expres-
sion, these results suggest that the EGFR pathway acts
through bantam miRNA to control tissue growth.EGFR Downregulates Capicua to Alleviate Repression
of bantam
Capicua has been reported to act downstream of EGFR
in tissue growth control [29]. Signaling via the Ras/MAPK
Figure 2. EGFR Pathway Regulates bantam Expression
(A–D) Confocal micrographs showing third instar wing discs expressing apG4 (anti-Gal4 shown in red). (A and C) apG4 controls and (B and D)
apG4 UAS-EGFR with bantam-lacZ and bantam-sensor as indicated (green in merged image and gray in single channel at right).
(E and F) Confocal micrographs showing details of third-instar wing discs containing clones of cells lacking EGFR (topF1, E), and Ras activity (RasDC40b, F)
marked by the absence of bGal protein (anti-bGal shown in red). bantam sensor expression is shown in green in themerged image. Clones aremarked by red
arrowheads in the bantam-sensor channel.
(G–I) Confocal micrographs showing third-instar wing discs. Discs were labeled with DAPI (red). Transgene expression was visualized by GFP fluorescence
(green, in H) or dsRED fluorescence (green, in I).
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examining the relationship between bantam and Capicua, we
first confirmed that elevated MAPK activity caused by expres-
sion of UAS-EGFR led to a reduction in Capicua protein levels
in the wing disc (Figure 3A; Cic protein shown in green/gray).
Intriguingly, coexpression ofUAS-EGFRwith aUAS-Cic trans-
gene, in place of the UAS-GFP control, restored Capicua
protein to near normal levels and suppressed the overgrowth
caused by EGFR overexpression (Figure 3B). Suppression of
the growth phenotype occurred despite strong activation of
theMAPK pathway, visualized by elevated levels of ERK phos-
phorylation (antibody to the doubly phosphorylated form of
the MAPK, ERK, is used as an in vivo readout of MAPK activity
[39]). The level of ERK phosphorylation induced by EGFR
overexpression was similar in discs coexpressing Capicua to
those in the control discs coexpressing GFP (Figures 3C
and 3D). This indicates that the ability of Cic to suppress
EGFR induced tissue overgrowth is not effected through
a block of EGFR-induced activation of the MAPK pathway.
These results indicate that downregulation of Capicua is
required in order for the EGFR/MAPK pathway to promote
growth. In light of this, we asked whether Capicua controls
bantam levels. cicQ474X is a loss-of-function mutant allele, for
which mutant clones have been reported to overgrow [29].
cicQ474X mutant clones showed reduced bantam-sensor
expression (Figure 3E), indicative of elevated bantam activity.
Taken together, these results suggest that Capicua acts to
limit bantam expression and that downregulation of Capicua
mediates the effects of EGFR on bantam. To further assess
this, we compared the effects of removing Ras with those of
concurrently removing Ras and capicua. In contrast to Ras
mutant clones, which showed higher bantam sensor levels,
cic/Ras double mutant clones showed low sensor levels (Fig-
ure 3F, compare with Figure 2F). Thus cic/Ras double mutant
clones were similar to clones mutant for capicua but different
from Ras mutant clones. These observations provide addi-
tional support to the idea that Capicua is a key effector ofEGFR/MAPK signaling in control of tissue growth. EGFR
signaling appears to induce bantam expression by alleviating
the effects of the repressor Capicua.
In addition to Capicua, the EGFRpathway is known to act via
three other transcription factors: Pointed, Tramtrack, and Yan.
Pointed and Tramtrack are expressed in the wing disc but Yan
is not. To ask whether the effects of EGFR on bantammight be
mediated via Pointed or Tramtrack, we produced clones of
cells mutant for the null alleles, pntD88and ttk1e11, and exam-
ined the effects on bantam sensor levels. In contrast to cic
clones, neither pnt nor ttk mutant clones showed any change
in bantam activity levels (Figure S2), suggesting that Capicua
is the major factor through which EGFR regulates bantam.
Hippo pathway signaling via Yki has been reported to
promote bantam expression [10, 11]. To test for the possibility
that the effects of Cic on bantammight be mediated indirectly,
via Yki, we examined expression of three known Yki targets
(CycE, Expanded, or DIAP1; [40, 41]) in cic mutant clones.
No changes were detected, making it unlikely that Cic acts
indirectly via the Hippo pathway (Figure S3).
Feedback Regulation: capicua Is a Direct bantam Target
The data presented thus far suggest a linear relationship in
which EGFR acts via Capicua to control bantam expression.
However, we observed that expression of the bantam sponge
not only limited the ability of UAS-EGFR to induce tissue over-
growth (Figures 2H and 2I), but it also reduced the ability of
UAS-EGFR to downregulate Capicua protein (Figure 4A,
compare with Figure 3A).
This prompted us to ask whether bantam induction might
contribute to regulation of Capicua by EGFR. Examination of
capicuamRNA for bantam target sites did not reveal any sites
in the 30 UTR, but candidate sites were found in the protein
coding sequence (Figure 4B) using RNAhybrid [42]. To test
the potential of these sites to mediate regulation by bantam,
we cloned a fragment including the sites into the 30UTR of
a luciferase reporter transgene and cotransfected into S2 cells
Figure 3. EGFR Regulates bantam by Inhibiting Cic
(A–D) Confocal micrographs showing third-instar wing discs labeled
with anti-Gal4 (red) to visualize apG4 activity. (A and C) apG4 UAS-EGFR
UAS-GFP, (B and D) apG4 UAS-EGFR UAS-cic, and (A and B) labeled
with antibody to Cic protein (green; gray in single channels shown at right).
(C and D) Labeled with anti-dp-ERK (green, gray).
(E and F) Clones of cells lacking capicua activity (cicQ474X, E), and cic Ras
double mutant clones (cicQ474X, RasDC40b, F) marked by the absence of
RFP (red). bantam sensor is shown in green and gray.
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control. As a positive control, we used a luciferase reporter
containing two perfect bantam sites in the 30UTR, comparable
to the bantam ‘‘sensor’’ used in vivo. Overexpression of
bantam in S2 cells reduced the expression of the sensor trans-
gene by 57% (Figure 4C; Student’s t test, p = 5.2E-04). The
intact capicua reporter was reduced by 30% (p = 0.01). Muta-
tion of the predicted sites eliminated regulation by bantam
(Figure 4C).
Next, we asked whether bantam was able to regulate
endogenous capicua expression in vivo. Overexpression
of bantam under the control of the hedgehog-Gal4 driver
reduced Capicua protein levels (Figures 4D and 4E). These
results suggest a regulatory feedback loop involving Capicua
and bantam (Figure 4F). EGFR acts to reduce Capicua protein
levels, which leads to an increase in bantam expression.
bantam can then feed back to further inhibit capicua. Interest-
ingly, reduction of bantam activity produced only a modest
increase in Capicua levels, suggesting that normal levels of
bantam are on the border of being limiting for Cic expression
(data not shown).EGFR and Yorkie Regulate bantam Independently
The Hippo pathway controls tissue growth through regulation
of the transcriptional coactivators YAP/Yorkie (reviewed in [4]).
Yorkie targets include regulators of cell proliferation and apo-
ptosis, cyclin E, DIAP, vein, wg, dMyc, E2F, and the bantam
miRNA [5, 10, 11, 40, 43–47]. Thus the Hippo and EGFR
pathways share bantam as a common target.
In this context, it is interesting that activation of the Hippo
pathway by Yap or Yorkie overexpression has been shown
to induce the expression of the EGFR-ligands amphiregulin
in mammalian cells and vein in Drosophila [46, 48]. This raised
the possibility that the effects of the Hippo pathway, mediatedvia Yorkie on bantam might be mediated via activation of
EGFR. We first confirmed that Yorkie expression could acti-
vate the EGFR/MAPK pathway in the wing disc (Figures 5A
and 5B). In this case, patched-Gal4was used to direct expres-
sion of UAS-Yorkie, and pathway activation was monitored
using anti-dpERK. This experiment was done using Gal80TS
to limit Yorkie induction to a 24 hr window in late third instar
so as to minimize disc overgrowth. The relatively normal
topology of the disc facilitates comparison of dpERK levels
in the affected and unaffected tissue.
Given that Yorkie can activate the MAPK pathway, we
wondered whether this was the main route by which Yorkie
acts on bantam. To address this, we asked whether blocking
EGFR activity could prevent Yorkie-induced upregulation of
bantam expression. nubbin-Gal4was used to direct transgene
expression in the wing pouch (Figure 5C). Expression of UAS-
yki led to increased bantam-lacZ and to massive overgrowth
(Figure 5D). Expression of UAS-yki together with a transgene
expressing a dominant-negative form of EGFR still showed an
increase in bantam-lacZ expression, although Yorkie-induced
tissue overgrowth was blocked (Figure 5E; for these ex-
periments, UAS-EGFRDN was expressed in place of the UAS-
GFP control). We confirmed inhibition of MAPK pathway
activity by monitoring dpERK levels in the assay (Figure S4).
Thus, Yorkie is able to induce bantam expression in cells
with a functional block at the level of EGFR. These results
suggest that Yki can act in two ways to induce bantam expres-
sion: via activation of EGFR/MAPK pathway and indepen-
dently of EGFR.
Consistent with the evidence that Yorkie can activate the
MAPK pathway, we observed that Yorkie overexpression
was able to cause a modest reduction in Cic protein levels
(Figures 5F and 5G). However, given that Yorkie also regulates
bantam, we wondered whether bantam contributes to the
effect of Yorkie on Cic. Coexpression of the bantam-sponge
together with yki reduced the extent of Cic downregulation
compared to coexpression of yki with the UAS-GFP control
transgene (Figures 5G and 5H). This suggests that Yki, by
activating bantam, contributes to Cic downregulation. Thus,
the transcriptional output of the Hippo pathway may serve to
lower the effective threshold of MAPK activity needed to
reduce Capicua.
Discussion
The ability of the EGFR pathway to drive tissue growth resides
in its ability to coordinately stimulate cell proliferation and
suppress apoptosis. Understanding how coordinated control
is achieved depends on identification of the effector mecha-
nisms that mediate these outputs along with the connections
to other growth regulatory pathways (reviewed in [15]). Our
results show that the bantam miRNA is a critical target of the
EGFR pathway. Further, we outline a mechanism by which
bantam serves as a link between the EGFR and Hippo
pathways.
Feedback Regulation between bantam and Capicua Links
Growth Control Pathways
In Drosophila, EGFR pathway effectors include the transcrip-
tion factors Pointed, Tramtrack, and Yan, and the HMG-box
repressor Capicua. Capicua has an important role in early
embryonic patterning and as a negative growth regulator [30,
32, 49]. Although several Capicua targets involved in em-
bryonic patterning have been identified [33], how Capicua
Figure 4. cic Is a bantam Target
(A) Confocal micrograph showing a third-instar wing disc of genotype: apG4 UAS-EGFR UAS-dsRED-bantam-sponge. The disc was labeled with anti-Cic
protein (red, gray in single channel). dsRed is shown in green.
(B) Schematic representation of the Capicua mRNA showing location of bantam binding sites (not to scale). Predicted pairing to bantam is shown below.
(C) Upper panel shows schematic representation of luciferase constructs for the capicua coding region fragment (red) placed into the 30UTR of the luciferase
reporter. Predicted bantam sites marked in blue. Lower panel shows luciferase assays testing regulation by bantam. Luciferase reporters were transfected
into S2 cells with the bantam expression plasmid or empty vector control. Data show mean 6 SD from three independent biological replicates, normalized
to the no miRNA control.
(D and E) Confocal micrographs showing Capicua protein expression in third-instar wing discs; (D) WT = wild-type control and (E) hh-Gal4 UAS-bantam-
GFP. Capicua is shown in red or gray. GFP is shown in green.
(F) Proposed model of the regulatory relationships.
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bantam as an important target of Capicua required to mediate
EGFR-dependent tissue growth.
A key finding of this study is the regulatory feedback rela-
tionship between bantam and Capicua. Each represses the
activity of the other. Viewed from the perspective of the
EGFR/MAPK pathway alone, the outcome of this relationship
would be signal amplification, with downregulation of Capicua
levels by bantam reinforcing direct MAPK-induced turnover of
Capicua protein. This adds a newmechanism to the repertoire
of positive and negative feedback loops affecting EGFR
pathway activity [15, 50]. These feedback mechanisms are
thought to be important in disease, and their regulation is
complex. Relatively little is known about Capicua in cancer,
although one recent study reports mutants in the human Cic
protein in oligodendroglioma [51].An alternative logic for the relationship between bantam and
Capicua may be seen in the fact that it links the output of the
EGFR pathway to the output of the Hippo pathway, mediated
through transcriptional regulation of bantam by Yorkie
[10, 11]. EGFR signaling via MAPK and bantam cooperate to
downregulate Capicua protein levels. Thus the transcriptional
output of the Hippo pathway via Yorkie can be seen as poten-
tiating EGFR signaling by ‘‘lowering’’ the effective threshold of
MAPK activity needed to reduce Capicua to a given level.
Alternatively, the lack of sufficient Yorkie activity would lower
bantam activity and thereby raise the threshold of EGFR
activity required to reach an effective level of Capicua downre-
gulation. This provides amechanism to ensure coordination of
the growth regulatory pathways. Signaling via the Hippo
pathway has also been shown to induce the EGFR ligand
amphiregulin to promote tissue growth in a nonautonomousFigure 5. Cooperative Activity of the EGFR and
Hippo Pathways
(A and B) Confocal micrographs showing EGFR
pathway activity in third-instar wing discs of the
following genotypes: ptc-Gal4 UAS-GFP and
ptc-Gal4 UAS-Yki UAS-GFP. Discs were labeled
with anti-dpERK (red, gray in single channel
shown below) and GFP to show ptc-Gal4 ex-
pressing cells is shown in green.
(C–E) bantam-lacZ expression (green, gray in
single channel at the right) in third-instar wing
discs.
(C) nub-Gal4 control.
(D) nub-Gal4 UAS-yki UAS-GFP.
(E) nub-Gal4 UAS-yki UAS-EGFRDN. Gal4 is
shown in red.
(F–H) Confocal micrographs showing Capicua
protein (red, gray in single channel) and GFP to
show ptc-Gal4 expressing cells (green). Geno-
types are as indicated.
Current Biology Vol 22 No 8
656manner [46]. Thus, there appear to be multiple levels of
crosstalk between these pathways.
miRNAs in Feedback Regulation of EGFR Pathway
Considerable evidence is emerging linking miRNAs to robust-
ness of regulatory feedback networks (reviewed in [52]). It is
intriguing that miRNAs are now implicated in regulation of all
three of the known transcriptional effectors of EGFR signaling.
miR-7 acts in two feed-forward loops downstream of EGFR to
control photoreceptor specification and differentiation in the
Drosophila eye [53]. EGFR acts via the transcription factors
Yan and Pointed. Yan is a direct target of miR-7. Yan also
represses miR-7 transcription directly as well as indirectly. In
the same cells, the ETS-1 factor Pointed-P1 activates miR-7
to repress Yan as well as acting directly to repress Yan. Use
of interlinked motifs is thought to provide stability to the cell
differentiation program controlled by EGFR [53]. Our findings
link bantam to regulation of a third EGFR transcriptional
effector, Capicua, in addition to its regulation by the Hippo
pathway. Coordination of diverse growth control inputs by
miRNAs might contribute to robustness.
Experimental Procedures
Transgenic Overexpression with the Gal4/UAS System
The stocks used are described in the following references: MS1096-Gal4
[54], nub-Gal4 and ap-Gal4 [55], ptc-Gal4 [56], UAS-yki [5], UAS-EGFR
[57], UAS-hpo [58], UAS-EGFRDN [59], UAS-RasV12 [38], UAS-EGFRRNAi
(ID number: 43267, Vienna Drosophila RNAi Center), UAS-bantam-GFP
[12], UAS-diap1 [60], and EP-3-1005 for overexpressing capicua [61].
Mosaic Analysis
Cloneswere generated using the FLP /FRT system (reviewed in [62]). Clones
were induced by heat shock for 1 hr at 37C. Clones generated in Minute
background were induced for 150 at 37C. Larvae were dissected 72 hr after
clone induction. Clones in the wing discs were generated in the following
genotypes:
hs-FLP/+; FRT42D topF1/FRT42D arm-lacZ; bantam-sensor/+
hs-FLP/+; bantam-sensor/+; FRT82 RasDC40b/FR82 arm-lacZ
hs-FLP/+; bantam-sensor/+; FRT82 cicQ474X/FR82 ubi-RFP
hs-FLP/+; bantam-sensor/+; FRT82 cicQ474X, RasDC40b /FR82 arm-lacZ
hs-FLP/+; bantam-sensor/+; FRT82 pntD88/FR82 arm-lacZ
hs-FLP/+; bantam-sensor/+; FRT82 ttk1e11/FR82 arm-lacZ
hs-FLP/+; CycE-lacZ/+; FRT82 cicQ474X/FR82 ubi-RFP
hs-FLP/+; Ex-lacZ/+; FRT82 cicQ474X/FR82 ubi-RFP
hsFLP/+; DIAP1-lacZ FRT82 cicQ474X/FR82 ubi-RFP
Mutant cells were marked by absence of RFP or b-gal.
bantam Expression
We used the following stocks to monitor bantam expression and activity,
respectively: bantam-lacZ (P{lacW}banL1170a) is described in FlyBase;
bantam-sensor [12].
Immunostaining
Rat polyclonal antibody to Cic protein was provided by Jordi Casanova
and used at 1:300 dilution. Other primary antibodies were rabbit anti-Gal4
(Santa Cruz Biotechnology), rabbit anti-bgal (Cappel), mouse anti-bgal
(Developmental Studies Hybridoma Bank), and anti-dpERK (Cell Signaling
Technology).
Spatiotemporal Gene Expression Targeting in Drosophila
We made use of the TARGET system developed by McGuire et al. [37] to
combine spatial and temporal control of gene expression. Adult flies
carrying the Gal4 drivers ptc-Gal4, ap-Gal4 and the thermosensitive version
of the Gal4 repressor Gal80 (Gal80ts) under the control of the tubulin
promoter (tubulin- Gal80ts) were crossed with transgenic flies bearing one
or more UAS transgenes. Eggs were collected over 24 hr at 18C and
allowed to develop at 18C to maintain the Gal80-dependent repressionof Gal4. Larvae were transferred to 29C to induce Gal4 for periods ranging
from 24–48 hr before being dissected and processed for antibody labeling.
Luciferase Reporter Assays
S2 cells were cotransfected with a plasmid expressing bantam under
the Drosophila tubulin promoter, a control construct expressing Renilla
luciferase and a firefly luciferase reporter fused with wild-type (WT) Capicua
sequences ormutant versionwith pairing region deleted as show in Figure 4.
As a positive control, bantam sensor luciferase reporter, which contains two
perfect bantambinding sites [12], was used during each transfection. Trans-
fections were performed in triplicates and dual luciferase assays were per-
formed 72 hr after transfection following the manufacturer’s instructions
(Promega). SD were from three independent transfection experiments.
Supplemental Information
Supplemental Information includes four figures and can be found with this
article online at doi:10.1016/j.cub.2012.02.050.
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